(19)
(11) EP 1 599 490 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
08.04.2009 Bulletin 2009/15

(45) Mention of the grant of the patent:
21.01.2009 Bulletin 2009/04

(21) Application number: 04716438.9

(22) Date of filing: 02.03.2004
(51) International Patent Classification (IPC): 
C07H 9/04(2006.01)
(86) International application number:
PCT/US2004/006263
(87) International publication number:
WO 2004/078769 (16.09.2004 Gazette 2004/38)

(54)

PROCESS FOR THE PREPARATION OF ANTICONVULSANT DERIVATIVES OF TOPIRAMATE

PROZESS ZUR HERSTELLUNG VON ANTIKONVULSIVEN DERIVATEN VON TOPIRAMAT

PROCEDE DE PREPARATION DE DERIVES DE TOPIRAMATE ANTICONVULSIFS

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
LV

(30) Priority: 04.03.2003 US 451863 P

(43) Date of publication of application:
30.11.2005 Bulletin 2005/48

(73) Proprietor: Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Titusville, NJ 08560 (US)

(72) Inventors:
  • BERKNER, Joachim, Ernst
    Suwanee, NH 30024 (US)
  • DUNCAN, Scott
    Madison, WI 53717 (US)
  • MILLS, John
    Hatfield, PA 19440 (US)

(74) Representative: Fisher, Adrian John et al
CARPMAELS & RANSFORD 43-45 Bloomsbury Square
London WC1A 2RA
London WC1A 2RA (GB)


(56) References cited: : 
US-A- 4 582 916
   
  • VATÈLE J-M ET AL: "Design and Reactivity of Organic Functional Groups - Preparation and Nucleophilic Displacement Reactions of Imimdazole-1-Sulfonates (Imidazylates)" TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 52, no. 32, 1996, pages 10557-10568, XP002261300 ISSN: 0040-4020
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).